Ono Pharmaceutical Co., Ltd.
OPHLF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.63B
Close$
$43.41
207.8% upside
Current Fair Value
207.8% upsideUndervalued by 207.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.63 Billion |
|---|---|
| Enterprise Value | $-95,073,457,900.00 |
| Annual dividend | $0.51 |
| Dividend yield | 3.55% |
| Earnings per Share | $150.19 |
| Beta | 0.14 |
| Outstanding Shares | 470,051,000 |
Return
| Return on Equity | 8.68% |
|---|---|
| Return on Assets | 6.94% |
| Return on Invested Capital | 11.46% |
Valuation & Multiples
| P/E Ratio | 14.21 |
|---|---|
| PEG | -178.85 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 1.95 |
| Enterprise Value to EBIT | 8.85 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$0.26
Consensus analyst estimateRevenue Estimate
$726.96 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 1, 2027
EPS Estimate
$0.30
Consensus analyst estimateRevenue Estimate
$768.07 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ono Pharmaceutical Co., Ltd.
4,206 employees
CEO: Gyo Sagara
Ono Pharmaceutical Co., Ltd., along with its affiliated companies, is engaged in the global development, manufacturing, procurement, and sale of a diverse range of pharmaceutical products and diagnostic tools. Its diverse oncology portfo...